Reneuron Share Discussion Threads

[investordave] 29/8/2019 16:43

Wtf is the closing price all about? How can the share price end the day level on a sale of 3 shares?

[bonzo] 29/8/2019 13:04

Keep at it Rayrac! It's working!

[martinfrench] 29/8/2019 12:06

Oh so it's you then

[rayrac] 29/8/2019 11:37

I keep adding, can’t see why not?

[rayrac] 21/8/2019 12:56

👉🏿👍🏽8525;

[martinfrench] 21/8/2019 10:10

Well it's join the dots time, these people wouldn't be needed if no product and they wouldn't accept if they weren't fairly sure either.

This plus the new guy in charge of deals can really only mean one thing

think this is bigger than most people think....especially like the nightstar guy, added experience of big sell offs.

[ayl30] 21/8/2019 09:07

Good rns today

[xow98] 19/8/2019 12:53

He is still selling off assets.

Woodford sells stake (20%) in Bristol tech firm Ultrahaptics for a ‘considerable profit’ per Telegraph

[shanur90] 15/8/2019 13:13

Hello. What is going on with woody stock in here

[lauders] 14/8/2019 09:25

News and no comment. Every bit helps as they say. This may be a slow burner on the exosome side but hopefully other news will come along soon to excite things around here.

[rayrac] 11/8/2019 20:41

Thanks both. See what transpires tomorrow? Good news anyway for future stroke victims!

[supernumerary] 11/8/2019 20:14

Rayrac - rene's stroke therapy is intended for patients who missed that 'golden hour', or even golden day or two, hence it's not directly competitive with the Athersys treatment. Given the nature of stroke, and its frequency, there will always be patients who cannot get to a specialist unit in time for these early response treatments, hence will be candidates for CTX.

[algernon2] 11/8/2019 17:08

Hi Rayrac, I was reading that article over coffee in town this afternoon and it looks promising.
This "golden window" for stem cells in stroke indication does worry me a bit as unlike the Retinitis Pigmentosa results which are stunning; the stroke results always seemed to be a bit more subjective and falling as they do within the possible placebo percentage range less immediately blatently successful.
Still if the treatment for RP comes good,it will be very quickly brought to market whilst the more onerous stroke trial(s) can go lumbering on more slowly.
I look forward to RP updates shortly.
PS who is going to the AGM on 12th September.Anyone?

[rayrac] 11/8/2019 16:10

Piece in the Telegraph today...competition for the stroke application from Athersys own stem cell based treatment... some of it below...


Stem cell breakthrough extends stroke ‘golden hour’
By Henry Bodkin
PEOPLE who have a stroke could have the chance of a full recovery thanks to a stem cell injection that extends the “golden hour” to a day and a half for most patients.
Regulators in Europe and the US are fast-tracking their approval processes after British patients who tried the treatment 36 hours after a stroke escaped permanent disability.
36
The number of hours after a stroke that the stem cell injection could be given to prevent permanent disability
People who suffer a stroke – roughly 100,000 a year in the UK – must get to a specialist hospital within about four hours to begin blood clot-busting treatment, although the best results come in the first 60 minutes.
Most do not make it in time, however, contributing to the almost two thirds of survivors leaving hospital with a disability.
The new intravenous solution developed in the US simultaneously regenerates damaged tissue, reduces harmful inflammation, and stimulates nerve cells that aid recovery in the brain. Millions of clinical doses can be harvested from a single donation of bone marrow.
A preliminary trial conducted in a handful of patients across the UK and US indicated they had a 15 per cent greater chance of making a full recovery after 90 days compared to those on a placebo. The increased likelihood rose to 24 per cent a year after the stroke. Among the people who made an “excellentR21; recovery were those given the stem cells a day and half after first showing symptoms.
This is crucial, because many people do not recognise the early signs of stroke, despite years of public information campaigns.
Independent experts have cautioned that more data is needed before hailing a “miracle”; treatment. However, the US Food and Drug Administration has awarded the technology fast-track designation, allowing a larger study to begin more quickly, a stance mirrored by watchdogs in Europe and Japan.

[small crow] 09/8/2019 13:34

Sterling soon down almost 20% since 2016 vote .... car manufacturing leaving UK (as well pharmaceuticals)..... we are already well on our way to hard times Rayrac!

[rayrac] 08/8/2019 23:16

I’m not a prophet, just a market watcher. :)

[rayrac] 06/8/2019 09:12

Like watching the tide going out, it will come back in though!

It’ll take good news to shift any share in this market, there’s no support out there.

And maybe Johnson and Brexit don’t give the right vibes, we in this country could be in for some hard times?

[bantam175] 05/8/2019 09:18

Someone is trying a big shorting exercise on these.

[manc10] 02/8/2019 09:07

Amy body seen raytard

[volsung] 01/8/2019 22:59

8.50 would help out I can’t deny

[rayrac] 01/8/2019 22:49

First, you can’t afford a house volsung and you certainly need £8.50 for your weekly shop :)

Where’s his straight jacket?